Skip to main content

NeoProteomics Licenses Technology from Case Western Reserve University

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Biomarker development and software firm NeoProteomics announced late on Friday that it has reached an exclusive option agreement to license technologies from Case Western Reserve University.

Under the agreement, NeoProteomics will have access to tools and biomarkers that will expand its portfolio in personalized medicine, according to a statement from the university. "The deal has potential to enhance various forms of treatment of cancer, diabetes, and inflammatory diseases," it added.

Founded in 2006 and based in Cleveland, NeoProteomics identifies and validates protein biomarkers "and seeks to spearhead the development of unique and improved analysis tools," Case Western Reserve said.

Financial and other terms of the deal were not disclosed.

NeoProteomics was co-founded by John Schenkel and Mark Chance. Schenkel is currently president and CEO of NeoProteomics.

Chance, who now serves as the company's chief scientific officer, is also director of the Case Center for Proteomics and Bioinformatics and is a professor and interim chair in the department of genetics at the university's School of Medicine.

NeoProteomics is distributing software licensed from Case Western Reserve called ProtMapMS, which automates mass spectrometry workflows. The university said the software has been licensed to major drug manufacturers and a number of prestigious research universities.

The company will offer other bioinformatics software, currently under development, from the Case Western Reserve for the integration of high-throughput genomics and proteomics data in clinical research.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.